CHEST 2025: INSIDE LOOK
BEC-oming Clear: Charting the Path to Precision Medicine in COPD Care
October 20 from 2:30 pm – 3:15 pm CDT
Learning Theater 4
Sponsored by: GSK
Program Description
Join us for a panelist discussion that brings together expert perspectives and the patient voice to address the burden of COPD and approaches that integrate biomarkers with collaborative decision-making.
This discussion will focus on the variability of blood eosinophil counts (BEC) across the COPD journey, interpreting situational fluctuations, and leveraging CBC testing for biomarker-driven decisions. Discussions will also explore the role of precision medicine and individual patient characteristics in shaping the future of personalized care.
Join us as we chart a clearer path to improving COPD management through precision medicine and holistic understanding.
Panelists
Reynold Panettieri, Jr, MD
Robert Wood Johnson, Rutgers University
Institute for Translational Medicine & Science
Vice Chancellor, Translational Medicine & Science; Director, Institute for Translational Medicine & Science Professor of Medicine
New Brunswick, New Jersey
Corinne Young, MSN, FNP, FCCP
Pulmonary and Critical Care Colorado Springs Pulmonary Consultants
Nurse Practitioner, Pulmonary and Critical Care
Colorado Springs, Colorado
